The global Embolic Protection Devices (EPDs) market size was USD 298.4 Million in 2022 and is expected to register a revenue CAGR of 8.5% over the forecast period, according to the latest report by Reports and Data.

Embolic Protection Devices (EPDs) serve as essential Medical Devices employed during specific cardiovascular procedures to avert the release of debris, including blood clots, into the bloodstream. These devices find common application in endovascular procedures like angioplasty and stenting, playing a crucial role in mitigating the risk of strokes and other severe complications. The embolic protection devices market is experiencing revenue growth owing to the escalating demand for minimally invasive cardiovascular procedures, exemplified by angioplasty and stenting. Furthermore, technological advancements have given rise to the development of more sophisticated EPDs, characterized by heightened efficacy and user-friendliness, thereby fueling market expansion. The upsurge in the prevalence of cardiovascular ailments, encompassing stroke and heart attack, has further amplified the demand for EPDs.

The embolic protection devices market is witnessing revenue growth primarily due to the escalating incidence of cardiovascular diseases, which in turn drives the demand for interventional procedures. This surge in demand is notably evident in the increased utilization of procedures such as angioplasty and stenting. Cardiovascular diseases remain a significant cause of mortality and morbidity on a global scale, with contributing factors including an aging population and evolving lifestyles. To address the associated risks, EPDs are utilized during these procedures to effectively capture and filter any potential debris, thereby minimizing the likelihood of embolization. The growing demand for interventional procedures acts as a key driver for revenue growth in the EPD market throughout the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/2518

Some of the prominent players profiled in the global Embolic Protection Devices (EPDs) market include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Cordis, Terumo Corporation, Johnson Johnson Services, Inc., Cook, Koninklijke Philips N.V., ASAHI INTECC CO., LTD., Contego Medical, Inc., Silk Road Medical, Claret Medical Group, and W. L. Gore Associates, Inc.

Some Key Highlights from the Report

• The distal filter device segment emerged as the dominant contributor to revenue in 2022, primarily attributed to its extensive acceptance and efficacy in capturing and filtering debris during interventional procedures like angioplasty and stenting. These devices are strategically positioned near the procedure site, in close proximity to the affected blood vessel, enabling them to efficiently trap and filter any potential loose debris during the course of the procedure. The widespread adoption of distal filter devices can be attributed to their user-friendly nature and remarkable efficacy, thus garnering favor among healthcare providers. Additionally, the growing demand for minimally invasive procedures to address cardiovascular diseases further propels the revenue growth of the distal filter device segment, as these devices play a pivotal role in mitigating the risks associated with embolization and other critical complications during such procedures.
• In 2022, the nitinol segment emerged as the frontrunner in terms of revenue share, primarily owing to its exceptional properties and versatility in the design of EPDs. Nitinol, a shape memory alloy composed of nickel and titanium, possesses the remarkable ability to regain its original shape even after being subjected to external forces. This unique characteristic renders nitinol an ideal material for crafting EPDs, enabling the creation of flexible yet resilient devices suitable for diverse interventional procedures. Alongside its shape memory attributes, nitinol exhibits exceptional biocompatibility and corrosion resistance, making it well-suited for application in medical devices. Furthermore, the escalating demand for minimally invasive procedures, such as angioplasty and stenting, propels the revenue growth of the nitinol segment, as this material finds extensive utilization in the design of EPDs for these specific procedures.
• In 2022, the cardiovascular diseases segment dominated the revenue share, emerging as the largest contributor. This segment can be further divided into sub-segments including coronary artery diseases, transcatheter aortic valve replacement, and saphenous vein graft diseases. Cardiovascular diseases continue to be the leading cause of global mortality, driving significant demand for treatments and interventions to manage these conditions effectively. Embolic protection devices play a vital role in minimizing the risk of complications during endovascular procedures conducted for cardiovascular diseases. By incorporating these devices, the occurrence of stroke, a common complication in endovascular procedures such as Percutaneous Coronary Intervention (PCI) and carotid artery stenting, can be effectively reduced.
• In 2022, the hospital segment emerged as the leader, accounting for the largest share of revenue. Hospitals serve as the primary users of embolic protection devices, as they are frequently involved in performing endovascular procedures. The segment's revenue growth is driven by the escalating demand for minimally invasive procedures and the increasing number of patients afflicted with cardiovascular diseases. Hospitals are proactively investing in state-of-the-art embolic protection devices to enhance the quality of patient care, thereby further propelling the revenue growth of this segment. Additionally, the market benefits from the growing emphasis on patient safety, the adoption of technology-driven solutions, and favorable reimbursement policies pertaining to endovascular procedures conducted within hospital settings.
• The North American market is projected to capture the largest share of revenue during the forecast period. The embolic protection devices market in North America is highly advanced, with the United States serving as a prominent hub for numerous major enterprises in the field. Key drivers for revenue growth in the region include increased investments in Research and Development (RD), technologically advanced infrastructure, and a rise in healthcare expenditure. The market has witnessed expansion with the introduction of new and sophisticated embolic protection devices. These devices, incorporating innovative technologies, offer heightened effectiveness, efficiency, and user-friendliness. Governments across North American countries are actively promoting the utilization of embolic protection devices and extending financial support to healthcare providers for the acquisition of these devices.
• Some of the prominent players profiled in the global Embolic Protection Devices (EPDs) market include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Cordis, Terumo Corporation, Johnson Johnson Services, Inc., Cook, Koninklijke Philips N.V., ASAHI INTECC CO., LTD., Contego Medical, Inc., Silk Road Medical, Claret Medical Group, and W. L. Gore Associates, Inc.
• Abbott bought Walk Vascular, a commercial-stage medical device business that develops minimally invasive mechanical aspiration thrombectomy systems to remove peripheral blood clots, on September 2, 2021. Walk Vascular's peripheral thrombectomy systems will be integrated into Abbott's existing endovascular product range. The acquisition's financial specifics have not been published.

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/embolic-protection-devices-market

For the purpose of this report, Reports and Data has segmented the global Embolic Protection Devices (EPDs) market on the basis of Device Type Outlook, Material Outlook, Application Outlook, End-use Outlook, and Regional Outlook:

Device Type Outlook (Revenue, USD Million; 2022 - 2032)

• Distal Filter Devices
• Distal Occlusion Devices
• Proximal Occlusion Devices

Material Outlook (Revenue, USD Million; 2022 - 2032)

• Nitinol
• Polyurethane

Application Outlook (Revenue, USD Million; 2022 - 2032)

• Cardiovascular Diseases
• Coronary Artery Disease
• Transcatheter Aortic Valve Replacement
• Saphenous Vein Graft Diseases
• Neurovascular Disease
• Peripheral Vascular Disease

End-use Outlook (Revenue, USD Million; 2022 - 2032)

• Hospitals
• Ambulatory Surgical Centers
• Others

Regional Outlook (Revenue, USD Million; 2022-2032)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Sweden
• BENELUX
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East Africa
• Saudi Arabia
• UAE
• South Africa
• Israel
• Rest of MEA

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2518

Thank you for reading our report. For more inquiry or query on customization, kindly get in touch with us. Our team will ensure you get the best report suited to your needs.

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyse consumer behaviour shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Power and Energy, and Chemicals. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Our Innovative Blogs @ https://www.reportsanddata.com/blogs